Risk/benefit analysis for the use and approval of thrombolytic, antiarrhythmic, and hypolipidemic agents.

Riskbenefit analysis for the use and approval of thrombolytic, antiarrhythmic, and hypolipidemic agents. Proceedings of the ninth annual symposium on new drugs & devices, October 27 & 28, 1988. Onder redactie van J.Morganroth en E.N.Moore. (Developments in cardiovascular medicine, vol. 100.) 301 bl., fig., tabellen. Kluwer, Boston 1989 (voor Nederland…